Introducing: Optomed & ViP - Health centers now have access to high-quality handheld fundus cameras and screening software at lower rates.

Since 2000, Community Health Ventures (CHV) has worked to connect health centers with best-in-class vendors. We are excited to announce our partnership with Optomed. Optomed's handheld fundus camera aims to transform the diagnostic process of blinding eye diseases such as rapidly increasing diabetic retinopathy. CHV’s position in the marketplace is unique and perfectly aligned to expand Optomed’s market presence and education in the growing health center movement.

 

There are four key components that define health centers & help them reach America's most underserved communities

REQUEST INFO

Diabetic Retinopathy

The number of diabetics has been growing rapidly around the world and one third of them suffer from diabetic retinopathy, the most common cause of vision loss in working-age adults.

 

Diabetic retinopathy is treatable, if detected early. However, due to the limited number of ophthalmologists and eye screening services, majority of diabetics globally do not have access to regular screenings.

OptoMed
OptoMed-4

Our Solution to a Global Problem

Effective eye screening prevents diabetes-related blindness and reduces overall health care costs.

 

We develop innovative and affordable solutions to enable eye screening for all patients worldwide.

Eye screening for everyone – wherever they are

The need for mobile eye examinations and remote consultation is rapidly increasing. Our handheld fundus camera, Optomed Aurora IQ, allow safe and accessible eye examinations.

OptoMed-1
OptoMed-3

Optomed handheld fundus cameras – patented high-quality technology

Our product range includes handheld fundus cameras, Optomed Aurora. In addition, we are developing fundus cameras that fit the needs of our customers.

Optomed Aurora - Saving Sight

The new era of eye care. Optomed Aurora is a market leader in handheld fundus imaging. With the Optomed Aurora, you can perform fundus screening anytime, anywhere.